Mainstay of Treatment for Myeloma, Dexamethasone, Shows Very Significant Survival Benefit for COVID-19 Patients

Updated June 23rd, 2020

Mainstay of Treatment for Myeloma, Dexamethasone, Shows Very Significant Survival Benefit for COVID-19 Patients

NOW
PLAYING
What Are the Various Treatment Options for Multiple Myeloma Induction Therapy?
NOW
PLAYING
Exciting New Immunotherapy Treatments for Multiple Myeloma
NOW
PLAYING
Multiple Myeloma: How Does a Stem Cell Transplant Work?
NOW
PLAYING
What Is a Stem Cell Transplant for Multiple Myeloma?
NOW
PLAYING
How Does a Stem Cell Transplant Work For Multiple Myeloma?
NOW
PLAYING
Phase One Of Multiple Myeloma Therapy

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.